BULENT OZPOLAT to Carcinogenesis
This is a "connection" page, showing publications BULENT OZPOLAT has written about Carcinogenesis.
Connection Strength
1.032
-
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2017 Feb 14; 8(7):11641-11658.
Score: 0.373
-
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1. Breast Cancer. 2022 Nov; 29(6):1106-1120.
Score: 0.137
-
miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K. Anticancer Agents Med Chem. 2022; 22(14):2607-2618.
Score: 0.131
-
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer. Anticancer Res. 2019 Feb; 39(2):529-532.
Score: 0.107
-
Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clin Cancer Res. 2018 09 01; 24(17):4225-4241.
Score: 0.102
-
FOXM1 transcriptionally regulates expression of integrin ?1 in triple-negative breast cancer. Breast Cancer Res Treat. 2017 Jun; 163(3):485-493.
Score: 0.094
-
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Oncotarget. 2016 Mar 29; 7(13):16619-35.
Score: 0.088